Valentina Di Francesco

Ms. Valentina Di Francesco

Italian Institute of Technology
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2023 in Biomedical Microdevices
Verified
Journal Article
Open access
PDF file
VFValentina Di Francesco
Valentina Di Francesco
DBDaniela Boso
Daniela Boso
Thomas L. MooreThomas L. Moore
Thomas L. Moore
BSBernhard A. Schrefler
Bernhard A. Schrefler
Paolo DecuzziPaolo Decuzzi
Paolo Decuzzi
The association of machine learning (ML) tools with the synthesis of nanoparticles has the potential to streamline the development of more efficient and effective nanomedicines. The continuous-flow synthesis of nanoparticles via microfluidics represents an ideal playground for ML tools, where multiple engineering parameters – flow rates and mixing configurations, type and concentrations of the reagents – contribute in a non-trivial fashion to determine the resultant morphological and pharmacological attributes of nanomedicines. Here we present the application of ML models towards the microfluidic-based synthesis of liposomes loaded with a model hydrophobic therapeutic agent, curcumin. After generating over 200 different liposome configurations by systematically modulating flow rates, lipid concentrations, organic:water mixing volume ratios, support-vector machine models and feed-forward artificial neural networks were trained to predict, respectively, the liposome dispersity/stability and size. This work presents an initial step towards the application and cultivation of ML models to instruct the microfluidic formulation of nanoparticles.

19 August 2021 in ACS Nano
Verified
Journal Article
Closed access
SBSean K Bedingfield
Sean K Bedingfield
JCJuan M. Colazo
Juan M. Colazo
MFMartina Di Francesco
Martina Di Francesco
FYFang Yu
Fang Yu
DLDanielle D. Liu
Danielle D. Liu
CDCraig Duvall
Craig Duvall

1 March 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
MFMartina Di Francesco
Martina Di Francesco
RPRosita Primavera
Rosita Primavera
MSMaria Summa
Maria Summa
MPMartina Pannuzzo
Martina Pannuzzo
VFValentina Di Francesco
Valentina Di Francesco
Paolo DecuzziPaolo Decuzzi
Paolo Decuzzi

1 July 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
MFMartina Di Francesco
Martina Di Francesco
SBSean K. Bedingfield
Sean K. Bedingfield
VFValentina Di Francesco
Valentina Di Francesco
JCJuan M. Colazo
Juan M. Colazo
FYFang Yu
Fang Yu
Paolo DecuzziPaolo Decuzzi
Paolo Decuzzi
Osteoarthritis (OA) is treated with the intra-articular injection of steroids such as dexamethasone (DEX) to provide short-term pain management. However, DEX treatment suffers from rapid joint clearance. Here, 20 × 10 μm, shape-defined poly(d,l-lactide-co-glycolide)acid microPlates (μPLs) are created and intra-articularly deposited for the sustained release of DEX. Under confined conditions, DEX release is projected to persist for several months, with only ∼20% released in the first month. In a highly rigorous murine knee overload injury model (post-traumatic osteoarthritis), a single intra-articular injection of Cy5-μPLs is detected in the cartilage surface, infrapatellar fat pad/synovium, joint capsule, and posterior joint space up to 30 days. One intra-articular injection of DEX-μPL (1 mg kg–1) decreased the expression of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6, and matrix metalloproteinase (MMP)-13 by approximately half compared to free DEX at 4 weeks post-treatment. DEX-μPL also reduced load-induced histological changes in the articular cartilage and synovial tissues relative to saline or free DEX. In sum, the μPLs provide sustained drug release along with the capability to precisely control particle geometry and mechanical properties, yielding long-lasting benefits in overload-induced OA. This work motivates further study and development of particles that provide combined pharmacological and mechanical benefits.

28 July 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
VFValentina Di Francesco
Valentina Di Francesco
DGDanila Gurgone
Danila Gurgone
RPRoberto Palomba
Roberto Palomba
MFMiguel Filipe Moreira Ferreira
Miguel Filipe Moreira Ferreira
TCTiziano Catelani
Tiziano Catelani
Paolo DecuzziPaolo Decuzzi
Paolo Decuzzi

1 August 2021 in Seminars in Immunology
Verified
Journal Article
Open access
NMNeil MacRitchie
Neil MacRitchie
VFValentina Di Francesco
Valentina Di Francesco
MFMiguel Filipe Moreira Ferreira
Miguel Filipe Moreira Ferreira
TGTomasz J. Guzik
Tomasz J. Guzik
PDPaolo Decuzzi
Paolo Decuzzi
PMPasquale Maffia
Pasquale Maffia
Theranostics, literally derived from the combination of the words diagnostics and therapy, is an emerging field of clinical and preclinical research, where contrast agents, drugs and diagnostic techniques are combined to simultaneously diagnose and treat pathologies. Nanoparticles are extensively employed in theranostics due to their potential to target specific organs and their multifunctional capacity. In this review, we will discuss the current state of theranostic nanomedicine, providing key examples of its application in the imaging and treatment of cardiovascular inflammation.